MKC vs ZNTL · P/E 8.4, rev $3.81B vs $257.7M cap
McCormick & Company Incorporated (MKC) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
MKC currently screens at market cap $13.56B and trailing P/E 8.4. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the MKC and ZNTL stock pages for the full models.
Not investment advice.